Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression

被引:23
作者
Borgatti, M
Finotti, A
Romanelli, A
Saviano, M
Bianchi, N
Lampronti, I
Lambertini, E
Penolazzi, L
Nastruzzi, C
Mischiati, C
Piva, R
Pedone, C
Gambari, R
机构
[1] Univ Ferrara, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy
[2] Univ Naples Federico II, Inst Biostruct & Bioimaging, CNR, Naples, Italy
[3] Univ Naples Federico II, Dept Biol Chem, Naples, Italy
[4] Univ Perugia, Dept Pharmaceut Chem & Technol, I-06100 Perugia, Italy
[5] Univ Ferrara, Ctr Biotechnol, I-44100 Ferrara, Italy
[6] Univ Ferrara, Interdisciplinary Ctr Study Inflammat, I-44100 Ferrara, Italy
关键词
transcription; decoy; delivery; gene therapy; peptide-nucleic acids; PNA-DNA chimeras;
D O I
10.2174/1389450043345155
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peptide nucleic acids (PNAs)-DNA chimeras have been recently described as DNA mimics constituted of a part of PNA and of a part of DNA. We have demonstrated that double stranded molecules based on PNA-DNA chimeras bind to transcription factors in a sequence-dependent manner. Accordingly. these molecules can be used for transcription factor decoy (,TFD) pharmacotherapy. Effects of double stranded PNA-DNA chimeras targeting NF=kappaB and Sp1 were determined on in vitro cultured human cells and were found to be comparable to those observed using double-stranded DNA decoys. The TFD molecules based on PNA-DNA chimeras can be further engineered by addition of short peptides facilitating cell penetration and nuclear localization. Therefore, these engineered molecules Could be of great interest for in vivo experiments for non-viral gene therapy of a variety of diseases, including neoplastic and viral diseases, for which the TFD approach has been already demonstrated as a very useful strategy.
引用
收藏
页码:735 / 744
页数:10
相关论文
共 86 条
[81]   Oligodeoxynucleotide targeted to the αv gene inhibits αv integrin synthesis, impairs osteoclast function, and activates intracellular signals to apoptosis [J].
Villanova, I ;
Townsend, PA ;
Uhlmann, E ;
Knolle, J ;
Peyman, A ;
Amling, M ;
Baron, R ;
Horton, MA ;
Teti, A .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (11) :1867-1879
[82]  
VINAYAK R, 1999, PEPTIDE NUCL ACIDS P
[83]   NFκB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts [J].
Vos, IHC ;
Govers, R ;
Gröne, HJ ;
Kleij, L ;
Schurink, M ;
De Weger, RA ;
Goldschmeding, R ;
Rabelink, TJ .
FASEB JOURNAL, 2000, 14 (05) :815-822
[84]   Targeted disruption of Stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4-driven TH2 cell response [J].
Wang, LH ;
Yang, XY ;
Kirken, RA ;
Resau, JH ;
Farrar, WL .
BLOOD, 2000, 95 (04) :1249-1257
[85]   Inhibition of NFκB activation using cis-element 'decoy' of NFκB binding site reduces neointimal formation in porcine balloon-injured coronary artery model [J].
Yamasaki, K ;
Asai, T ;
Shimizu, M ;
Aoki, M ;
Hashiya, N ;
Sakonjo, H ;
Makino, H ;
Kaneda, Y ;
Ogihara, T ;
Morishita, R .
GENE THERAPY, 2003, 10 (04) :356-364
[86]   Identification of cis-elements of the human endothelin-A receptor gene and inhibition of the gene expression by the decoy strategy [J].
Yamashita, J ;
Yoshimasa, T ;
Arai, H ;
Hiraoka, J ;
Takaya, K ;
Miyamoto, Y ;
Ogawa, Y ;
Itoh, H ;
Nakao, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (26) :15993-15999